Cargando…
Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264297/ https://www.ncbi.nlm.nih.gov/pubmed/37249751 http://dx.doi.org/10.1007/s13555-023-00934-y |
| _version_ | 1785058296612257792 |
|---|---|
| author | Gisondi, Paolo Gottlieb, Alice B. Elewski, Boni Augustin, Matthias McBride, Sandy Tsai, Tsen-Fang de la Loge, Christine Fierens, Frederik López Pinto, José M. Tilt, Nicola Lebwohl, Mark |
| author_facet | Gisondi, Paolo Gottlieb, Alice B. Elewski, Boni Augustin, Matthias McBride, Sandy Tsai, Tsen-Fang de la Loge, Christine Fierens, Frederik López Pinto, José M. Tilt, Nicola Lebwohl, Mark |
| author_sort | Gisondi, Paolo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10264297 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102642972023-06-15 Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) Gisondi, Paolo Gottlieb, Alice B. Elewski, Boni Augustin, Matthias McBride, Sandy Tsai, Tsen-Fang de la Loge, Christine Fierens, Frederik López Pinto, José M. Tilt, Nicola Lebwohl, Mark Dermatol Ther (Heidelb) Publisher Correction Springer Healthcare 2023-05-30 /pmc/articles/PMC10264297/ /pubmed/37249751 http://dx.doi.org/10.1007/s13555-023-00934-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Publisher Correction Gisondi, Paolo Gottlieb, Alice B. Elewski, Boni Augustin, Matthias McBride, Sandy Tsai, Tsen-Fang de la Loge, Christine Fierens, Frederik López Pinto, José M. Tilt, Nicola Lebwohl, Mark Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) |
| title | Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) |
| title_full | Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) |
| title_fullStr | Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) |
| title_full_unstemmed | Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) |
| title_short | Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) |
| title_sort | publisher correction: long-term health-related quality of life in patients with plaque psoriasis treated with certolizumab pegol: three-year results from two randomised phase 3 studies (cimpasi-1 and cimpasi-2) |
| topic | Publisher Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264297/ https://www.ncbi.nlm.nih.gov/pubmed/37249751 http://dx.doi.org/10.1007/s13555-023-00934-y |
| work_keys_str_mv | AT gisondipaolo publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT gottliebaliceb publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT elewskiboni publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT augustinmatthias publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT mcbridesandy publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT tsaitsenfang publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT delalogechristine publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT fierensfrederik publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT lopezpintojosem publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT tiltnicola publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 AT lebwohlmark publishercorrectionlongtermhealthrelatedqualityoflifeinpatientswithplaquepsoriasistreatedwithcertolizumabpegolthreeyearresultsfromtworandomisedphase3studiescimpasi1andcimpasi2 |